Zimmer Biomet’s sales rise as reported earnings per share fall
Zimmer Biomet’s November 4 earnings report covers the global business of the Warsaw, Indiana-based orthopedic-products company. It reported $2.063 billion in net sales for the quarter ended September 30, up 3.1% from the same period of 2025.
Zimmer Biomet’s November 4 earnings report covers the global business of the Warsaw, Indiana-based orthopedic-products company. It reported $2.063 billion in net sales for the quarter ended September 30, up 3.1% from the same period of 2025.
Higher sales did not translate into higher reported earnings per share. Diluted earnings under U.S. generally accepted accounting principles were $1 a share, compared with $1.16 a year earlier. The company’s adjusted measure was $1.90 a share in both periods. That is a non-GAAP figure, separate from the reported result. The report does not provide a Warsaw-area sales or employment total.
Report a correction · Editorial standards · Our source directory
BusinessIndy examines this development and its implications for Indiana businesses and communities using the linked sources.
SOURCE STATUS: One-source report; independent confirmation pending.
Sources
- Zimmer Biomet — original financial results: Warsaw-based Zimmer Biomet reports $2.063 billion in third-quarter sales ↗
- investor.zimmerbiomet.com ↗
Publication date of the linked source has not been verified. A sourced news brief; no independent staff reporting is implied. Prepared with AI assistance; source-dependent claims remain attributed in the article.
Related coverage
- H5N1 detected in two operationally connected Newton County dairy herds, WISH‑TV reports
- Indiana awards $13.1M GROW grant to Region 7 to expand rural healthcare services and workforce
- Indianapolis-based Eli Lilly reports Foundayo tied to modeled cuts in 10‑year diabetes and cardiovascular risk
Reader discussion
Join the discussion. Every comment is checked before publication. Community rules and appeals